Comments
Loading...

BioLine Rx

BLRXNASDAQ
Logo brought to you by Benzinga Data
$0.1050
0.003503.45%
At close: -
$0.1051
0.000100.10%
After Hours: 7:59 PM EDT
BioLine Rx Ltd is expected to split Thursday, January 30, 2025 with a ratio of 1:40

BioLine Rx (NASDAQ:BLRX) Stock, Earnings Estimates, EPS, And Revenue

BioLine Rx reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Mar 25
EPS Estimate
$0.000
Quarterly Revenue Estimate
$7.72M
Annual Revenue
(as of Sep 30)
$21.99M

Analyze the earnings history of BioLine Rx using advanced sorting and filters.

Data brought to you by Benzinga APIs

BioLine Rx (BLRX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32024-11-25$-0.07$-0.1030.0 %
Q22024-08-15$0$-0.14100.0 %
Q12024-05-28$-0.01$-0.2996.5 %
Q32023-11-20$-0.26$-0.21-23.8 %

BioLine Rx (BLRX) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q32024-11-25$4.94M$4.12M20.0 %
Q22024-08-15$5.39M$3.93M37.2 %

FAQ

Q

When is BioLine Rx (NASDAQ:BLRX) reporting earnings?

A

BioLine Rx (BLRX) is scheduled to report earnings on March 25, 2025. The last reported earnings were for reported on November 25, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for BioLine Rx (NASDAQ:BLRX)?

A

The Actual EPS was $-0.07, which beat the estimate of $-0.10.

Q

What were BioLine Rx’s (NASDAQ:BLRX) revenues?

A

The Actual Revenue was $4.9M, which beat the estimate of $4.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch